Picture of Percheron Therapeutics logo

PER — Percheron Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Antisense Therapeutics Says Commencement Of James Garner As CEO And Managing Director

Aug 7 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * COMMENCEMENT OF JAMES GARNER AS CHIEF EXECUTIVE OFFICER
AND
MANAGING DIRECTOR
    * COMMENCEMENT EFFECTIVE 7 AUGUST 2023

Source text for Eikon:  ID:nASX3R9g5W 
Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Percheron Therapeutics

See all news